Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GKOS Glaukos	$103.50 -0.1%	$95.71	$77.10 ▼ $163.71	$5.92B	0.82	739,359 shs	289,937 shs
PHG Koninklijke Philips	$24.17 -1.4%	$23.72	$20.61 ▼ $31.57	$23.61B	0.76	899,654 shs	871,452 shs
SNN Smith & Nephew SNATS	$30.26 +0.3%	$29.00	$23.69 ▼ $31.72	$13.21B	0.69	815,726 shs	274,870 shs
ZBH Zimmer Biomet	$93.67 +0.2%	$94.20	$89.22 ▼ $116.71	$18.50B	0.71	1.81 million shs	927,032 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GKOS Glaukos	-0.17%	+2.25%	+9.45%	+23.77%	-13.12%
PHG Koninklijke Philips	-1.51%	+0.27%	+5.94%	+9.45%	-7.09%
SNN Smith & Nephew SNATS	+0.33%	+0.21%	+3.86%	+14.92%	+20.41%
ZBH Zimmer Biomet	+0.18%	+1.89%	+1.92%	-12.83%	-12.10%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GKOS Glaukos	4.453 of 5 stars	4.4	1.0	0.0	4.4	2.7	1.7	0.6
PHG Koninklijke Philips	3.4902 of 5 stars	0.0	5.0	1.7	0.0	2.0	0.0	3.1
SNN Smith & Nephew SNATS	3.6987 of 5 stars	1.0	5.0	2.5	0.0	3.0	0.0	4.4
ZBH Zimmer Biomet	4.9033 of 5 stars	3.2	3.0	2.5	3.7	3.2	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GKOS Glaukos	2.75	Moderate Buy	$134.67	30.11% Upside
PHG Koninklijke Philips	3.00	Buy	N/A	N/A
SNN Smith & Nephew SNATS	2.00	Hold	$28.00	-7.47% Downside
ZBH Zimmer Biomet	2.30	Hold	$111.33	18.86% Upside

Current Analyst Ratings Breakdown

Latest GKOS, PHG, ZBH, and SNN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/12/2025	ZBH Zimmer Biomet	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$115.00 ➝ $101.00
5/7/2025	ZBH Zimmer Biomet	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Outperform ➝ Market Outperform	$140.00 ➝ $125.00
5/6/2025	ZBH Zimmer Biomet	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$101.00
5/6/2025	ZBH Zimmer Biomet	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$138.00 ➝ $115.00
5/6/2025	GKOS Glaukos	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$110.00 ➝ $72.00
5/6/2025	ZBH Zimmer Biomet	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$120.00 ➝ $104.00
5/6/2025	ZBH Zimmer Biomet	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$119.00 ➝ $104.00
5/6/2025	ZBH Zimmer Biomet	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$125.00 ➝ $112.00
5/6/2025	ZBH Zimmer Biomet	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$115.00 ➝ $95.00
5/6/2025	ZBH Zimmer Biomet	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$128.00 ➝ $105.00
5/6/2025	ZBH Zimmer Biomet	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$113.00 ➝ $98.00

(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GKOS Glaukos	$383.48M	15.42	N/A	N/A	$13.91 per share	7.44
PHG Koninklijke Philips	$17.98B	1.29	$3.05 per share	7.92	$13.86 per share	1.74
SNN Smith & Nephew SNATS	$5.81B	2.28	$3.17 per share	9.55	$12.04 per share	2.51
ZBH Zimmer Biomet	$7.68B	2.41	$13.21 per share	7.09	$62.67 per share	1.49

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GKOS Glaukos	-$146.37M	-$2.37	N/A	N/A	N/A	-31.40%	-10.66%	-8.06%	7/30/2025 (Estimated)
PHG Koninklijke Philips	-$758.55M	$0.43	56.21	12.52	0.69	2.11%	10.97%	4.57%	7/29/2025 (Estimated)
SNN Smith & Nephew SNATS	$412M	$2.16	14.01	15.13	0.93	N/A	N/A	N/A	8/5/2025 (Estimated)
ZBH Zimmer Biomet	$903.70M	$4.52	20.72	10.56	2.16	11.86%	12.73%	7.34%	8/6/2025 (Estimated)

Latest GKOS, PHG, ZBH, and SNN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q2 2025	GKOS Glaukos	-$0.26	N/A	N/A	N/A	$115.49 million	N/A
7/29/2025	Q2 2025	PHG Koninklijke Philips	$0.2907	N/A	N/A	N/A	$4.35 billion	N/A
5/6/2025	Q1 2025	PHG Koninklijke Philips	$0.14	$0.27	+$0.13	$0.09	$4.10 billion	$4.31 billion
5/5/2025	Q1 2025	ZBH Zimmer Biomet	$1.77	$1.81	+$0.04	$0.91	$1.89 billion	$1.91 billion
4/30/2025	Q1 2025	GKOS Glaukos	-$0.33	-$0.22	+$0.11	-$0.32	$102.78 million	$106.66 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GKOS Glaukos	N/A	N/A	N/A	N/A	N/A
PHG Koninklijke Philips	$0.82	3.39%	N/A	190.70%	N/A
SNN Smith & Nephew SNATS	$0.89	2.94%	N/A	41.20%	N/A
ZBH Zimmer Biomet	$0.96	1.02%	N/A	21.24%	N/A

Latest GKOS, PHG, ZBH, and SNN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/30/2025	ZBH Zimmer Biomet	quarterly	$0.24	1.03%	6/26/2025	6/26/2025	7/31/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GKOS Glaukos	0.09	6.49	5.62
PHG Koninklijke Philips	0.60	1.28	0.79
SNN Smith & Nephew SNATS	0.62	2.89	1.33
ZBH Zimmer Biomet	0.53	2.44	1.46

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GKOS Glaukos	99.04%
PHG Koninklijke Philips	13.67%
SNN Smith & Nephew SNATS	25.64%
ZBH Zimmer Biomet	88.89%

Insider Ownership

Company	Insider Ownership
GKOS Glaukos	5.80%
PHG Koninklijke Philips	N/A
SNN Smith & Nephew SNATS	1.00%
ZBH Zimmer Biomet	1.39%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GKOS Glaukos	780	57.14 million	53.83 million	Optionable
PHG Koninklijke Philips	66,678	962.92 million	N/A	Optionable
SNN Smith & Nephew SNATS	17,349	437.97 million	433.59 million	Optionable
ZBH Zimmer Biomet	17,000	197.85 million	195.10 million	Optionable

GKOS, PHG, ZBH, and SNN Headlines

Recent News About These Companies

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Leeward Investments LLC MA

1 hour ago | marketbeat.com

Goelzer Investment Management Inc. Reduces Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

1 hour ago | marketbeat.com

DAVENPORT & Co LLC Buys 3,893 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

2 hours ago | marketbeat.com

New York State Teachers Retirement System Trims Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 3 at 4:47 AM | marketbeat.com

Mirae Asset Global Investments Co. Ltd. Grows Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 3 at 4:21 AM | marketbeat.com

Robeco Institutional Asset Management B.V. Sells 7,063 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 2 at 4:00 AM | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives $111.53 Consensus PT from Analysts

July 2 at 2:33 AM | americanbankingnews.com

Barnes Dennig Private Wealth Management LLC Takes Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

July 1 at 6:20 AM | marketbeat.com

6,696 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Acquired by IRON Financial LLC

June 30, 2025 | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Consensus Rating of "Hold" by Brokerages

June 29, 2025 | marketbeat.com

ZBH - Zimmer Biomet Holdings Inc Executives | Morningstar

June 28, 2025 | morningstar.comM

ZBH - Zimmer Biomet Holdings Inc Executives | Morningstar

June 28, 2025 | morningstar.comM

Allspring Global Investments Holdings LLC Sells 737,158 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

June 28, 2025 | marketbeat.com

QSM Asset Management Ltd Takes $9.28 Million Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

June 28, 2025 | marketbeat.com

Illinois Municipal Retirement Fund Sells 21,312 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

June 28, 2025 | marketbeat.com

Q2 EPS Estimates for Zimmer Biomet Lowered by Zacks Research

June 28, 2025 | americanbankingnews.com

ZBH - Zimmer Biomet Holdings Inc Dividends | Morningstar

June 27, 2025 | morningstar.comM

Peering Into Zimmer Biomet Holdings's Recent Short Interest

June 27, 2025 | benzinga.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Acquired by Border to Coast Pensions Partnership Ltd

June 27, 2025 | marketbeat.com

Zacks Research Reduces Earnings Estimates for Zimmer Biomet

June 27, 2025 | marketbeat.com

Zimmer Biomet’s Q1 Earnings Call: Our Top 5 Analyst Questions

June 27, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GKOS, PHG, ZBH, and SNN Company Descriptions

Glaukos NYSE:GKOS

$103.50 -0.13 (-0.13%)

Closing price 07/3/2025 03:30 PM Eastern

Extended Trading

$103.42 -0.08 (-0.07%)

As of 07/3/2025 04:20 PM Eastern

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Koninklijke Philips NYSE:PHG

$24.17 -0.35 (-1.43%)

Closing price 07/3/2025 03:30 PM Eastern

Extended Trading

$24.18 +0.00 (+0.02%)

As of 07/3/2025 04:54 PM Eastern

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Smith & Nephew SNATS NYSE:SNN

$30.26 +0.10 (+0.33%)

As of 07/3/2025 03:56 PM Eastern

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Zimmer Biomet NYSE:ZBH

$93.67 +0.17 (+0.18%)

Closing price 07/3/2025 03:30 PM Eastern

Extended Trading

$94.44 +0.77 (+0.82%)

As of 07/3/2025 04:26 PM Eastern

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time